David Mountcastle Sells 6,453 Shares of Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 6,453 shares of the firm’s stock in a transaction dated Thursday, March 12th. The stock was sold at an average price of $21.90, for a total value of $141,320.70. Following the completion of the transaction, the chief financial officer owned 233,369 shares of the company’s stock, valued at approximately $5,110,781.10. This represents a 2.69% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

David Mountcastle also recently made the following trade(s):

• On Friday, March 13th, David Mountcastle sold 6,565 shares of Privia Health Group stock. The shares were sold at an average price of $21.52, for a total value of $141,278.80.
• On Monday, March 9th, David Mountcastle sold 5,829 shares of Privia Health Group stock. The stock was sold at an average price of $22.84, for a total transaction of $133,134.36.
• On Friday, March 6th, David Mountcastle sold 5,177 shares of Privia Health Group stock. The shares were sold at an average price of $23.15, for a total transaction of $119,847.55.
• On Thursday, February 26th, David Mountcastle sold 5,361 shares of Privia Health Group stock. The shares were sold at an average price of $25.00, for a total transaction of $134,025.00.
• On Friday, February 27th, David Mountcastle sold 7,697 shares of Privia Health Group stock. The stock was sold at an average price of $25.05, for a total transaction of $192,809.85.

Privia Health Group Trading Up 0.6%

Privia Health Group stock opened at $22.10 on Wednesday. Privia Health Group, Inc. has a 1-year low of $18.77 and a 1-year high of $26.51. The firm has a market capitalization of $2.73 billion, a PE ratio of 130.00, a price-to-earnings-growth ratio of 1.38 and a beta of 0.82. The firm’s 50 day simple moving average is $22.80 and its 200 day simple moving average is $23.61.

Privia Health Group (NASDAQ:PRVA) last announced its quarterly earnings results on Thursday, February 26th. The company reported $0.25 EPS for the quarter, beating the consensus estimate of $0.04 by $0.21. The firm had revenue of $541.17 million during the quarter, compared to the consensus estimate of $516.61 million. Privia Health Group had a net margin of 1.08% and a return on equity of 3.06%. The business’s quarterly revenue was up 17.4% compared to the same quarter last year. During the same period last year, the firm earned $0.21 EPS. Research analysts forecast that Privia Health Group, Inc. will post 0.14 earnings per share for the current year.

Wall Street Analysts Forecast Growth

PRVA has been the subject of several recent analyst reports. Wolfe Research set a $31.00 target price on Privia Health Group in a research report on Tuesday, January 6th. Truist Financial raised their price target on Privia Health Group from $31.00 to $33.00 and gave the company a “buy” rating in a report on Monday, March 2nd. Piper Sandler reiterated an “overweight” rating and set a $36.00 price target on shares of Privia Health Group in a research report on Thursday, February 26th. Royal Bank Of Canada initiated coverage on Privia Health Group in a report on Friday, January 9th. They set an “outperform” rating and a $31.00 price objective for the company. Finally, Stephens restated an “overweight” rating and issued a $32.00 price objective on shares of Privia Health Group in a research report on Thursday, December 4th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $31.00.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in PRVA. Bayban purchased a new stake in Privia Health Group during the fourth quarter valued at about $26,000. Invesco Ltd. boosted its holdings in shares of Privia Health Group by 5.1% in the 4th quarter. Invesco Ltd. now owns 427,615 shares of the company’s stock worth $10,139,000 after purchasing an additional 20,652 shares in the last quarter. Wellington Management Group LLP boosted its holdings in shares of Privia Health Group by 3.8% in the 4th quarter. Wellington Management Group LLP now owns 233,446 shares of the company’s stock worth $5,535,000 after purchasing an additional 8,531 shares in the last quarter. Millennium Management LLC increased its position in shares of Privia Health Group by 19.0% during the 4th quarter. Millennium Management LLC now owns 702,744 shares of the company’s stock valued at $16,662,000 after purchasing an additional 112,428 shares during the last quarter. Finally, Gotham Asset Management LLC increased its position in shares of Privia Health Group by 22.4% during the 4th quarter. Gotham Asset Management LLC now owns 36,995 shares of the company’s stock valued at $877,000 after purchasing an additional 6,773 shares during the last quarter. 94.48% of the stock is currently owned by hedge funds and other institutional investors.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.